Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry.
about
Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myelomaAdditional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in malignant lymphoma or multiple myeloma patientsEstablishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonistsBiased and g protein-independent signaling of chemokine receptorsFine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.Stoichiometry and geometry of the CXC chemokine receptor 4 complex with CXC ligand 12: molecular modeling and experimental validation.The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells.Role of CXCR4 in HIV infection and its potential as a therapeutic target.Pharmacological modulation of chemokine receptor function.Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.A Lentiviral CXCR4 overexpression and knockdown model in colorectal cancer cell lines reveals plerixafor-dependent suppression of SDF-1α-induced migration and invasion.Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusionFluorescent CXCR4 chemokine receptor antagonists: metal activated binding
P2860
Q24186469-CA54199A-3225-438A-9EA3-8812D6DB86A6Q24202384-8632528F-194F-41DB-BDED-B4F8A4750E96Q24802476-8F6F8B7C-7929-4E45-BB23-1CE6CB8016E9Q26823970-A5F60D73-C3D9-40FB-8393-7ED323452D51Q33587317-928C6242-6ECB-40BD-AB98-5F3773A008B0Q34752104-50E42FA6-3FC2-471A-9196-67C9D5A10980Q35804766-5881E2C2-3826-419E-8066-7754FD86CEFBQ37772888-EAB2907D-2693-4BF5-94D0-B460A86C7A76Q37893687-1CD320F8-FD5C-4E1F-AD45-553977AD1407Q38542935-E7980112-28E5-4008-BD94-636D5EF8161DQ39460665-1B3A3E79-51E5-434B-B498-2FF17EED7D20Q40384583-4613706D-DA65-4CF8-9076-97775A6E9C9EQ41862449-E50C7733-63CD-4FDE-837D-0336AE5C8167
P2860
Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Mutations at the CXCR4 interac ...... ibody binding and HIV-1 entry.
@en
Mutations at the CXCR4 interac ...... ibody binding and HIV-1 entry.
@nl
type
label
Mutations at the CXCR4 interac ...... ibody binding and HIV-1 entry.
@en
Mutations at the CXCR4 interac ...... ibody binding and HIV-1 entry.
@nl
prefLabel
Mutations at the CXCR4 interac ...... ibody binding and HIV-1 entry.
@en
Mutations at the CXCR4 interac ...... ibody binding and HIV-1 entry.
@nl
P2093
P2860
P50
P1433
P1476
Mutations at the CXCR4 interac ...... ibody binding and HIV-1 entry.
@en
P2093
Gary Bridger
Katrien Princen
Lars-Ole Gerlach
Sigrid Hatse
P2860
P304
P356
10.1016/S0014-5793(03)00609-4
P407
P577
2003-07-01T00:00:00Z